Evidence of in vivo basophil activation in chronic idiopathic urticaria

Clinical and Experimental Allergy

Volumn 36, Issue 6, 2006, Pages 770-776

  Vasagar, K ^a   Vonakis, B M ^a   Gober, L M ^a   Viksman, A ^a   Gibbons Jr , S P ^a   Saini, S S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Autoantibodies; Basophils; Cell surface markers; Cellular activation; Chronic urticaria

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CD63 ANTIGEN; CD69 ANTIGEN; CELL SURFACE MARKER; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN E RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BASOPHIL; BLOOD SAMPLING; CELL LYSATE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SERUM FACTOR; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BASOPHILS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-3; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, IGE; URTICARIA;

EID: 33745647328     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02494.x     Document Type: Article

References (40)

1. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002; 346:175-9.
2. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99:461-5.
3. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101:672-6.
4. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107:1056-62.
5. Sabroe RA, Fiebiger E, Francis DM et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002; 110:492-9.
6. Sabroe RA, Poon E, Orchard GE et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999; 103:484-93.
7. Grattan CE. Basophils in chronic urticaria. J Investig Dermatol Symp Proc 2001; 6:139-40.
8. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109:694-700.
9. Grattan CE, Dawn G, Gibbs S, Francis DM. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003; 33:337-41.
10. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976; 57:1369-77.
11. Saini SS, Vasagar K, Huang F, Gibbons S, Jr., Vonakis BM. Signaling defects in basophils in chronic urticaria. J Allergy Clin Immunol 2003; 111:5178.
12. Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102:651-8.
13. Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody-435. J Allergy Clin Immunol 1991; 88:328-38.
14. Bochner BS. Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000; 106:S292-302.
15. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy 2004; 34:332-9.
16. Yoshimura C, Yamaguchi M, Iikura M et al. Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J Allergy Clin Immunol 2002; 109:817-23.
17. Buehring HJ, Seiffert M, Giesert C et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/ phosphodiesterase 3. Blood 2001; 97:3303-5.
18. Boumiza R, Monneret G, Forissier MF et al. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 2003; 33:259-65.
19. Hauswirth AW, Natter S, Ghannadan M et al. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol 2002; 110:102-9.
20. Binder M, Fierlbeck G, King T, Valent P, Buehring HJ. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol 2002; 129:160-8.
21. Buehring HJ, Simmons PJ, Pudney M et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 1999; 94:2343-56.
22. MacGlashan DW Jr. Graded changes in the response of individual human basophils to stimulation: distributional behavior of events temporally coincident with degranulation. J Leukoc Biol 1995; 58:177-88.
23. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599-604.
24. MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 91:605-15.
25. De Swerdt A, Van Den Keybus C, Kasran A et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD63. J Allergy Clin Immunol 2005; 116:662-7.
26. Gyimesi E, Sipka S, Danko K et al. Basophil CD63 expression assay on highly sensitized atopic donor leukocytes - a useful method in chronic autoimmune urticaria. Br J Dermatol 2004;151:388-96.
27. Hidvegi B, Nagy E, Szabo T et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003; 132:177-82.
28. Saini SS, Richardson JJ, Wofsy C, Lavens-Phillips S, Bochner BS, Macglashan DW Jr. Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils. J Allergy Clin Immunol 2001; 107:832-41.
29. Gilbert HS, Ornstein L. Basophil counting with a new staining method using alcian blue. Blood 1975; 46:279-86.
30. Saini SS, MacGlashan DW Jr., Sterbinsky SA et al Down-regulation of human basophil IgE and FcεRIα surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol 1999; 162:5624-30.
31. Saini SS, Klion AD, Holland SM, Hamilton RG, Bochner BS, MacGlashan DW Jr. The relationship between serum IgE and surface FcεRI on human leukocytes in various diseases: correlation of expression with FcεRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 2000; 103:514-20.
32. Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975; 7:283-90.
33. Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 2002; 129:254-60.
34. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression - inhibitory effects of antiinflammatory drugs. J Allergy Clin Immunol 2000; 105:552-60.
35. Horn MP, Pachlopnik JM, Vogel M et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001; 15:2268-74.
36. Miescher SM, Horn MP, Pachlopnik JM, Baldi L, Vogel M, Stadler BM. Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies 2001; 10:119-26.
37. MacGlashan DW Jr., Bochner BS, Adelman DC et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158:1438-45.
38. Horn MP, Gerster T, Ochensberger B et al. Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999; 29:1139-48.
39. Pachlopnik JM, Horn MP, Fux M et al. Natural anti-Fcepsilon-RIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004; 22:43-51.
40. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101:243-51.